YAP1 and macular degeneration: Therefore, it is of interest to understand the molecular docking interaction of verteporfin(a derivative of benzo-porphyrin) with the WW domain of YAP (clinically used for photo-dynamic therapy in macular degeneration)as a potential WW domain-ligand modulator by inhibition.